World-wide, researchers and practitioners in psychiatry are increasingly interested in the effectiveness of such substances as MDMA, LSA, and psylocibin in treating such disorders as addiction, post-traumatic stress disorder, and other types of depressive and anxiety. Although most of these substances were declared illegal in most countries during the 1970s, research into their use was widespread during the mid-20th century, and has recently returned to the spotlight. Psychotherapy enhanced by some of these substances has been demonstrated to be highly effective where pharmaceuticals have not. People undergoing these therapies appear to be truly healed, rather than merely treated. This, though, raises the philosophical question ...
By the 1960’s, more than 1000 peer-reviewed research articles detailed the use of psychedelic compou...
This work provides an in-depth analysis of the most relevant aspects of psychedelic-assisted therapy...
Psychedelic research became throttled in the 1970s, though the clinical interest for psychedelics ha...
World-wide, researchers and practitioners in psychiatry are increasingly interested in the effective...
We are amidst a \u27Renaissance\u27 in the field of psychedelic psychiatry. For several decades, fol...
Mental disorders are rising while development of novel psychiatric medications is declining. This st...
With roughly 44.7 million individuals struggling with mental health problems, it is important that n...
Depression and anxiety are debilitating mental health conditions that affect a large portion of the ...
The word "psychedelic" (psyche (i.e., the mind or soul) and delos (i.e., to show)) has Greek origin ...
Users of psychedelic drugs frequently report various types of healing effects after the experience h...
Psychedelics show increasing therapeutic potential in the treatment of anxiety, depression, and addi...
Our chapter traces the origins of the psychoanalytic method back to experiences of non-ordinary stat...
Addressing global mental health is a major twenty-first century challenge. Current treatments have r...
Recent clinical trials show that psychedelics such as LSD and psilocybin can be given safely in cont...
Objective Research into psychedelic therapy models has shown promise for the treatment of specific ...
By the 1960’s, more than 1000 peer-reviewed research articles detailed the use of psychedelic compou...
This work provides an in-depth analysis of the most relevant aspects of psychedelic-assisted therapy...
Psychedelic research became throttled in the 1970s, though the clinical interest for psychedelics ha...
World-wide, researchers and practitioners in psychiatry are increasingly interested in the effective...
We are amidst a \u27Renaissance\u27 in the field of psychedelic psychiatry. For several decades, fol...
Mental disorders are rising while development of novel psychiatric medications is declining. This st...
With roughly 44.7 million individuals struggling with mental health problems, it is important that n...
Depression and anxiety are debilitating mental health conditions that affect a large portion of the ...
The word "psychedelic" (psyche (i.e., the mind or soul) and delos (i.e., to show)) has Greek origin ...
Users of psychedelic drugs frequently report various types of healing effects after the experience h...
Psychedelics show increasing therapeutic potential in the treatment of anxiety, depression, and addi...
Our chapter traces the origins of the psychoanalytic method back to experiences of non-ordinary stat...
Addressing global mental health is a major twenty-first century challenge. Current treatments have r...
Recent clinical trials show that psychedelics such as LSD and psilocybin can be given safely in cont...
Objective Research into psychedelic therapy models has shown promise for the treatment of specific ...
By the 1960’s, more than 1000 peer-reviewed research articles detailed the use of psychedelic compou...
This work provides an in-depth analysis of the most relevant aspects of psychedelic-assisted therapy...
Psychedelic research became throttled in the 1970s, though the clinical interest for psychedelics ha...